Goralatide (TFA)
Product Specifications
UNSPSC Description
Goralatide TFA is an inhibitor of cell cycle progression. Goralatide TFA enhances selectivity of hyperthermic purging of human progenitor cells. Goralatide TFA has the potential for the research of leukemia[1].
Target Antigen
Others
Type
Natural Products
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/goralatide-tfa.html
Purity
99.0
Solubility
DMSO : 100 mg/mL (ultrasonic)|H2O : 250 mg/mL (ultrasonic)
Smiles
O=C(O)[C@H]1N(C([C@H](CCCCN)NC([C@H](CC(O)=O)NC([C@H](CO)NC(C)=O)=O)=O)=O)CCC1.OC(C(F)(F)F)=O
Molecular Weight
601.53
References & Citations
[1]Wierenga PK, et al. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression. Bone Marrow Transplant. 1998;21(1):73-78.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-129283A/Goralatide-TFA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-129283A/Goralatide-TFA-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1796568-94-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![[Tyr69,Ala71,72,Lys74]-C3a (69-77) [Tyr-Ala-Ala-Ala-Leu-Lys-Leu-Ala-Arg; MW 946.20]](https://cdn.genprice.uk/genprice/genprice4.png)
SP-89387-5 5mg
[Tyr69,Ala71,72,Lys74]-C3a (69-77) [Tyr-Ala-Ala-Ala-Leu-Lys-Leu-Ala-Arg; MW 946.20]
Ask
View Details 
E4839Hu-01 48 Well
Human Endoplasmic Reticulum To Nucleus Signalling 1, ERN1 ELISA KIT
Ask
View Details